NeoNeuro SAS and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group are pleased to announce that they have entered into a collaboration to validate the performance of the Aptamarker platform for Alzheimer's disease...
At the International level
“iPEPS-ICM” means “the incubator and nursery of enterprises Paris-Salpêtrière.” Eighteen months after it opened, the structure has become the first accelerator of innovation dedicated to diseases of the brain in France, and already hosts 15...